1. 10 Multiplex genotyping of matched EBUS TBNA and cfDNA samples in advanced NSCLC patients. (January 2016) Authors: Lyons, J.; O'Brien, C.; Krussel, S.; Finn, S.P.; Cuffe, S.; O'Connell, F.; Gately, K. Journal: Lung cancer Issue: Volume 91(2016)Supplement 1 Page Start: S4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 11P Association of VISTA-expressing CD66b-positive neutrophils, with response and survival benefit from pembrolizumab in advanced malignant pleural mesothelioma. (December 2022) Authors: Homicsko, K.; Zygoura, P.; Tissot, S.; Norkin, M.; Popat, S.; Curioni-Fontecedro, A.; O'Brien, M.E.R.; Pope, T.; Shah, R.; Kammler, R.; Finn, S.P.; Coukos, G.; Dafni, U.; Peters, S.; Stahel, R.A. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 4 Identification and targeting of the DNA repair gene, XRCC6BP1, in cisplatin resistant NSCLC. (January 2016) Authors: Barr, M.P.; Foley, E.; He, Y.; Young, V.; Ryan, R.; Nicholson, S.; Leonard, N.; O'Byrne, K.J.; Finn, S.P.; Cuffe, S. Journal: Lung cancer Issue: Volume 91(2016)Supplement 1 Page Start: S2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 5 A novel microRNA signature associated with cisplatin resistant NSCLC holds both diagnostic and prognostic biomarker potential. (January 2016) Authors: MacDonagh, L.; Gray, S.G.; Cuffe, S.; Finn, S.P.; Young, V.; Ryan, R.; Nicholson, S.; Leonard, N.; Yin Sui, J. Sze; O'Byrne, K.J.; Barr, M.P. Journal: Lung cancer Issue: Volume 91(2016)Supplement 1 Page Start: S2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 6 Cisplatin induces the emergence and expansion of a distinct cancer stem cell (CSC) population in NSCLC. (January 2016) Authors: MacDonagh, L.; Gray, S.G.; Cuffe, S.; Finn, S.P.; Young, V.; Ryan, R.; Nicholson, S.; Leonard, N.; O'Byrne, K.J.; Barr, M.P. Journal: Lung cancer Issue: Volume 91(2016)Supplement 1 Page Start: S3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 7 Cancer stem cells: targeting aldehyde dehydrogenase 1 (ALDH1) as a novel strategy to overcome cisplatin resistance in NSCLC. (January 2016) Authors: MacDonagh, L.; Gray, S.G.; Cuffe, S.; Finn, S.P.; O'Byrne, K.J.; Barr, M.P. Journal: Lung cancer Issue: Volume 91(2016)Supplement 1 Page Start: S3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 8 Exploitation of the vitamin A/retinoic acid axis in the re-sensitisation of cisplatin resistant NSCLC cells. (January 2016) Authors: MacDonagh, L.; Gray, S.G.; Cuffe, S.; Finn, S.P.; O'Byrne, K.J.; Barr, M.P. Journal: Lung cancer Issue: Volume 91(2016)Supplement 1 Page Start: S3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 86 When RON MET TAM: potential interventions for mesothelioma therapy. (January 2016) Authors: Baird, A.; Easty, D.; Mohamed, B.M.; Jarzabek, M.A.; Sheils, L.; Soltermann, A.; Raeppel, S.; Mcdonagh, L.; Clarke, G.; Crosbie-Staunton, K.; Stanfill, B.; Nonaka, D.; Goparju, C.M.; Prina-Mello, A.; Volkov, Y.; Murer, B.; Fennell, D.; O'Donnell, D.M.; Mutti, L.; Barr, M.P. Journal: Lung cancer Issue: Volume 91(2016)Supplement 1 Page Start: S31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 8: Are circRNAs potentially useful for the early detection of lung cancer?. (January 2017) Authors: Lin, R.C.; Reid, G.; Mutti, L.; Ryan, A.W.; Nicholson, S.; Leonard, N.; Young, V.; Ryan, R.; Finn, S.P.; Cuffe, S.; Gray, S.G. Journal: Lung cancer Issue: Volume 103(2017)Supplement 1 Page Start: S4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 9: EGFR-AS1: A potential biomarker for sensitivity to EGFR TKIs in NSCLC?. (January 2017) Authors: Heery, R.; Nicholson, S.; Leonard, N.; Young, V.; Ryan, R.; Finn, S.P.; Cuffe, S.; Gray, S.G. Journal: Lung cancer Issue: Volume 103(2017)Supplement 1 Page Start: S5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗